Business
Press Release Mar 10 2023
Natco Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled "NATCO announces the Launch of additional strengths for the Generic Version of Revlimid�� (lenalidomide capsules), in the USA".
About this update from Natco Pharma Limited
[{"type":"text","content":" Natco Pharma Limited has informed the Exchange regarding a press release dated March 10, 2023, titled \"NATCO announces the Launch of additional strengths for the Generic Version of Revlimid�� (lenalidomide capsules), in the USA\". View Attachment","length":378,"tagName":"div"}]